Read the document here.
Global Access to TB Drug Susceptibility Testing, 2020
The European Medicines Agency has updated its stance on Deltyba—with implications for children with DR-TB. Read about it here.
The driving contributor to safer, all-oral TB regimens may not be who you think, with more credit due to the government than private enterprises. Read about it here.